Legacy samples in Finnish biobanks : social and legal issues related to the transfer of old sample collections into biobanks

Show simple item record

dc.contributor University of Helsinki, University of Turku en
dc.contributor University of Helsinki, Academic Disciplines of the Faculty of Social Sciences en
dc.contributor University of Helsinki, Helsinki Collegium for Advanced Studies en
dc.contributor.author Salokannel, Marjut
dc.contributor.author Tarkkala, Heta
dc.contributor.author Snell, Karoliina
dc.date.accessioned 2019-12-18T14:27:01Z
dc.date.available 2019-12-18T14:27:01Z
dc.date.issued 2019-10-16
dc.identifier.citation Salokannel , M , Tarkkala , H & Snell , K 2019 , ' Legacy samples in Finnish biobanks : social and legal issues related to the transfer of old sample collections into biobanks ' , Human Genetics , vol. 138 , no. 11-12 , pp. 1287-1299 . https://doi.org/10.1007/s00439-019-02070-0 en
dc.identifier.issn 1432-1203
dc.identifier.other PURE: 127480320
dc.identifier.other PURE UUID: 82b1ff17-2346-4805-a386-2206391888e2
dc.identifier.other WOS: 000490529300001
dc.identifier.other ORCID: /0000-0002-2643-6676/work/66365363
dc.identifier.other ORCID: /0000-0001-5284-3091/work/66366836
dc.identifier.uri http://hdl.handle.net/10138/308522
dc.description.abstract Biobank operations started officially in Finland in 2013 when the Biobank Act defining and regulating biobank operations came into force. Since then, ten biobanks have been established and they have started to collect new prospective samples with broad consent. The main corpus of biobank samples, however, consists of approximately 10 million “legacy samples”. These are old diagnostic or research samples that were transferred to biobanks in accordance with the Biobank Act. The focus of this article is on ambiguities concerning these legacy samples and their transfer in terms of legality, human rights, autonomy, and social sustainability. We analyse the Finnish biobank operations in the context of international regulation, such as the European Convention of Human Rights, the Oviedo Convention, European Charter of Fundamental Rights, the GDPR, and EU Clinical Trials Regulation, and show that the practice of using legacy samples is at times problematic in relation to this regulatory framework. We argue that the prevailing interpretations of these regulations as translated into the Finnish biobank practices undermine the autonomy of individuals by not giving individuals a right to consent or an actionable right to opt-out of the transfer of these legacy samples to the biobank. This is due to the fact that individuals are not given effective notification of such transfers. Thus, issues regarding the legal status of the biobank samples and the social sustainability of biobank operations remain a challenge for biobanks in Finland despite governmental efforts to create pioneering, comprehensive, and enabling legislation. fi
dc.format.extent 13
dc.language.iso eng
dc.relation.ispartof Human Genetics
dc.rights en
dc.subject 1184 Genetics, developmental biology, physiology en
dc.subject privacy en
dc.subject health en
dc.title Legacy samples in Finnish biobanks : social and legal issues related to the transfer of old sample collections into biobanks en
dc.type Article
dc.description.version Peer reviewed
dc.identifier.doi https://doi.org/10.1007/s00439-019-02070-0
dc.type.uri info:eu-repo/semantics/other
dc.type.uri info:eu-repo/semantics/publishedVersion

Files in this item

Total number of downloads: Loading...

Files Size Format View
Salokannel2019_ ... mplesInFinnishBiobanks.pdf 676.7Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record